https://www.sec.gov/ix?doc=/Archives/edgar/data/1619856/000161985623000112/crbu-20230926.htm
Caribou Biosciences Received Notice That AbbVie Has Decided To Terminate Their Collaboration And License Agreement Effective Oct. 25; The Termination Is Due To AbbVie's Strategic Focus
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.